EXODIAB: Excellence of Diabetes Research in Sweden
1611 – 1620 of 4132
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
C-peptide predicts all-cause and cardiovascular death in a cohort of individuals with newly diagnosed type 2 diabetes. The Skaraborg diabetes register
(
- Contribution to journal › Article
-
Mark
Sharing data for future research—engaging participants’ views about data governance beyond the original project : a DIRECT Study
(
- Contribution to journal › Article
-
Mark
No direct effect of SGLT2 activity on glucagon secretion
(
- Contribution to journal › Article
-
Mark
High versus low added sugar consumption for the primary prevention of cardiovascular disease
(
- Contribution to journal › Article
-
Mark
Epigenetics in Human Obesity and Type 2 Diabetes
(
- Contribution to journal › Scientific review
-
Mark
Disparities in prediabetes and type 2 diabetes prevalence between indigenous and nonindigenous populations from Southeastern Mexico : The Comitan Study
(
- Contribution to journal › Article
-
Mark
Accelerating Biomarker Discovery Through Electronic Health Records, Automated Biobanking, and Proteomics
(
- Contribution to journal › Article
-
Mark
ApoAI-derived peptide increases glucose tolerance and prevents formation of atherosclerosis in mice
(
- Contribution to journal › Article
-
Mark
Glycogen metabolism is impaired in the brain of male type 2 diabetic Goto-Kakizaki rats
(
- Contribution to journal › Article
-
Mark
Skin autofluorescence as a measure of advanced glycation end product levels is associated with carotid atherosclerotic plaque burden in an elderly population
(
- Contribution to journal › Article